Victorian patients with frontotemporal dementia to trial new drug
IN a world-first trial, Victorians with a devastating form of dementia that strikes in middle age will be given a drug aimed at slowing the disease. Thousands of Australians have the condition, which causes changes in personality and…
Read MoreDiscovery Award to support new test for sepsis
Burnet Institute’s Global Health Diagnostics Laboratory has been awarded a prestigious Longitude Prize Discovery Award to facilitate the development of a laboratory-based sepsis assay into a point-of-care test. The award will also support the Laboratory’s bid for a…
Read MoreBioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017
With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…
Read MoreAttention all Victorians attending AusBiotech 2017 in Adelaide
The Victorian Government will be hosting a stand in the Exhibition Hall for the duration of the AusBiotech Conference, promoting Victoria as a leading global location for biotechnology. You are encouraged to drop by the stand to connect…
Read More
